dupilumab
sanofi,regeneron
['dupilumab', 'derm']
attending #aad2023? supplement your schedule with efficacy and safety of dupilumab in patients with erythrodermic atopic dermatitis: a post hoc analysis of 6 randomized clinical trials, from jama dermatology. free to read online during the meeting 
JAMA #Dermatology publishes information concerning the skin, its diseases, and their treatment. #skincare